Treatment Of Patients With Rare Diseases And Requiring Permanent Replacement Therapy (27 03 03 06) _ Tocilizumab 162 Mg Ready-To-Use Syringe (Funding Will Be Implemented Within The Framework Of The Appropriations Approved By The 2025 State Budget). (EXPIRED)